Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics

Alzheimer’s Disease (AD) currently affects more than 5 million Americans, with numbers expected to grow dramatically as the population ages. The pathophysiological changes in AD patients begin decades before the onset of dementia, highlighting the urgent need for the development of early diagnostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Trushina, Eugenia, Dutta, Tumpa, Persson, Xuan-Mai T., Mielke, Michelle M., Petersen, Ronald C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658985/
https://www.ncbi.nlm.nih.gov/pubmed/23700429
http://dx.doi.org/10.1371/journal.pone.0063644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658985/
https://www.ncbi.nlm.nih.gov/pubmed/23700429
http://dx.doi.org/10.1371/journal.pone.0063644

Ejemplares similares